At a glance
ClinicalIndex Comparison RecordN/ACompleted· 113 enrolled
Drug / intervention
Liquid Embolicdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Liquid Embolization of Arterial Hemorrhages in the Peripheral Vasculature: The LAVA Study
In Brief
A clinical study evaluating Liquid Embolic for Peripheral Arterial Hemorrhage. Completed, enrolled 113 participants across 9 sites.
Detailed Summary
To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Hemorrhage
CountriesUnited States
CollaboratorsSyntactx
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartApr 2021
Primary CompletionAug 2022
TodayJul 2026
First PostedDec 2, 2020
Enrollment StartApr 14, 2021
Primary CompletionAug 17, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.6 years ago
Interventions
Liquid Embolicdevice
Lava Liquid Embolic System (LES)